Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
Research News
Conference News
Plain English
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
What We Know
Animal Models
Drugs in Trials
Research Tools
Community Calendar
General Information
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Search or browse comments posted on research articles or SRF news stories. And share your thoughts and ideas by posting your own comments.
Search Comments
Words in  Comment:   AND
Comments By:    Select Commentator  AND
Posted Date:  From
  To       AND
Sort By: 
1 to 6 of 6 results
Neufeld R. on Thank you for the opportunity to join this live discussion, though I regret that I cannot... 29 May 2008. 

Neufeld R. on WHAT WE KNOW: Functional abnormalities occur in a number of brain systems, including prefrontal and temporal cortices and subcortical structures., Generally missing are cognitive paradigms that could potentiate greater informational returns... 19 Dec 2007. 

Neufeld R. on WHAT WE KNOW: Cognitive tests are challenging for many, but not all, patients. The greatest deficits appear on tasks such as verbal memory, performance IQ, and coding tasks., An informed mapping of spared and affected cognitive functions, along with affected... 12 Nov 2007. 

Neufeld R. on WHAT WE KNOW: Functional abnormalities occur in a number of brain systems, including prefrontal and temporal cortices and subcortical structures., Progress in understanding the interplay of cognitive function and symptom expression... 12 Nov 2007. 

Neufeld R. on WHAT WE KNOW: All drugs with established anti-psychotic effects decrease dopamine neurotransmission, but anti-psychotic drugs are not effective for all schizophrenia symptoms. Among available agents, the atypical antipsychotic clozapine is the most effective for most patients, however it carries unique risks for some., Progress toward a fuller understanding of DA-antagonist-symptom relations arguably rests on... 12 Nov 2007. 

Neufeld R. on WHAT WE KNOW: Schizophrenia has a heterogeneous presentation, with disorganized, positive, and negative symptoms having different levels of prominence across time and across individuals., As has been shown for any system of complex interactions among component variables, coming to... 12 Nov 2007. 

1 to 6 of 6 results

See our upcoming webinar, Cognition and Treatment Resistance in Schizophrenia, to be held Monday, November 10, 12:00 to 1:30 p.m. EST.

See our last webinar, Research Domain Criteria (RDoC) Applied to Verbal Hallucinations, held May 28, 2014.

Check out our Schizophrenia Bulletin Forum Discussion: Prefrontal Inefficiency Is Associated With Polygenic Risk for Schizophrenia.

Research Participants
Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright